24 Mar 2025 Augustine Therapeutics raises oversubscribed EUR 78 million Series A financing round Member news
20 Mar 2025 Biotech as a critical economic asset for Europe: WifOR Institute study updated for EuropaBio Multiple categories
10 Mar 2025 Agomab Announces Positive Topline Phase 2a Interim Results for AGMB-129 in Fibrostenosing Crohn’s Disease Member news
04 Mar 2025 InnoSer Strengthens Neurology Platform with Acquisition of Remynd’s CRO Business Multiple categories
26 Feb 2025 4Tissue secures an additional €1.5M in funding and appoints Dr. Katleen Verleysen as independent chair of the board Member news
25 Feb 2025 FDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025 Member news
More info? Ellen Telleir Communication Coordinator linkedin.com/in/ellentelleir/ +32 9 241 80 41 ellen.telleir@flanders.bio Contact us
